SCHEMBL5694533

SCHEMBL5694533

CO/N=C(/C(=O)O)c1csc(N)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.59
LMNA P02545 2/20 0.59
GAA P10253 1/20 0.59
NR1I2 O75469 3/20 0.48
PGR P06401 1/20 0.48
PTGS2 P35354 1/20 0.48
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 1/20 0.48
ITGB1 P05556 2/20 0.47
ITGA4 P13612 2/20 0.47
HTR2C P28335 1/20 0.45
ALB P02768 1/20 0.43
PPARG P37231 1/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
SLC22A11 Q9NSA0 1/20 0.43
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL968132 1.00 MAPT (0.59) MAPTLMNAGAANR1I2PGR
SCHEMBL968131 1.00 MAPT (0.59) MAPTLMNAGAANR1I2PGR
Hydrochloric Acid SCHEMBL7020610 0.98 MAPT (0.58) MAPTLMNAGAANR1I2PGR
Hydrochloric Acid SCHEMBL3135048 0.98 MAPT (0.58) MAPTLMNAGAANR1I2PGR
Hydrogen Sulfide SCHEMBL28193705 0.98 MAPT (0.58) MAPTLMNAGAANR1I2PGR
SCHEMBL3737087 0.88 MAPT (0.48) MAPTLMNAGAANR1I2PGR
SCHEMBL8120449 0.88 MAPT (0.48) MAPTLMNAGAANR1I2PGR
SCHEMBL3929244 0.88 MAPT (0.48) MAPTLMNAGAANR1I2PGR
SCHEMBL19236061 0.88 MAPT (0.48) MAPTLMNAGAANR1I2PGR
SCHEMBL9982497 0.88 MAPT (0.48) MAPTLMNAGAANR1I2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112321606-B Preparation method of ceftizoxime sodium and intermediate thereof 福安药业集团重庆博圣制药有限公司 2022-05-17 CN claimed
CN-112321606-A Preparation method of ceftizoxime sodium and intermediate thereof 福安药业集团重庆博圣制药有限公司 2021-02-05 CN claimed
CN-110903303-A Preparation method of cefepime hydrochloride compound 山东金城柯瑞化学有限公司 2020-03-24 CN claimed
WO-2005100369-A1 DEPLETION OF E-ISOMERS IN PREPARATION OF Z-ENRICHED 3-(2-SUBSTITUTED VINYL) CEPHALOSPORINS RANBAXY LABORATORIES LIMITED (IN) 2005-10-27 WO claimed
WO-2024251301-A1 GSPT1 PROTEIN DEGRADER CONTAINING OXIME STRUCTURE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 中国药科大学 2024-12-12 WO disclosed
CN-119080738-A GSPT1 protein degradation agent containing oxime structure and preparation method and application thereof 中国药科大学 2024-12-06 CN disclosed
CN-112321606-B Preparation method of ceftizoxime sodium and intermediate thereof 福安药业集团重庆博圣制药有限公司 2022-05-17 CN disclosed
CN-112321606-B Preparation method of ceftizoxime sodium and intermediate thereof 福安药业集团重庆博圣制药有限公司 2022-05-17 CN disclosed
CN-112321606-A Preparation method of ceftizoxime sodium and intermediate thereof 福安药业集团重庆博圣制药有限公司 2021-02-05 CN disclosed
CN-112321606-A Preparation method of ceftizoxime sodium and intermediate thereof 福安药业集团重庆博圣制药有限公司 2021-02-05 CN disclosed
CN-110903303-A Preparation method of cefepime hydrochloride compound 山东金城柯瑞化学有限公司 2020-03-24 CN disclosed
CN-110903303-A Preparation method of cefepime hydrochloride compound 山东金城柯瑞化学有限公司 2020-03-24 CN disclosed
US-4294960-A 7-[2-(2-Aminothiazol-4-yl)-2-cyclopentyloxyiminoacetamido]-3-cephem-4-carboxylic acid (synisomer) FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-10-13 US disclosed
EP-0002774-B1 PROCESS FOR ACYLATING 7AMINOCEPHEM DERIVATIVES HOECHST AKTIENGESELLSCHAFT (DE) 1981-09-23 EP disclosed
EP-0002765-B1 CEPHALOSPORIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION HOECHST AKTIENGESELLSCHAFT (DE) 1981-09-02 EP disclosed
US-4279818-A CEPHALOSPORINS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-07-21 US disclosed
US-4225707-A 2-Lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds FUJISAWA PHARMACEUTICAL COMPANY, LIMITED (JP) 1980-09-30 US disclosed
US-4166115-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1979-08-28 US disclosed
EP-0002765-A1 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions and their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1979-07-11 EP disclosed
US-4152433-A ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1979-05-01 US disclosed